← SynDRA
PREXASERTIB
SynDRA canonical compound SYN0038166 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CHEK1 |
| Mechanism of action | CHK inhibitor |
All known targets
Mechanisms of action (all sources)
- CHEK1 INHIBITOR
- Serine/threonine-protein kinase Chk1 inhibitor
- CHEK2 INHIBITOR
- Serine/threonine-protein kinase Chk2 inhibitor
- RPS6KA1 INHIBITOR
- CHK inhibitor
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- LY-2606368
- LY2606368
- UNII-820NH671E6
- 820NH671E6
- Prexasertib [USAN]
- 5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)pyrazine-2-carbonitrile
- 5-({5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl}amino)pyrazine-2-carbonitrile
- 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile
- SCHEMBL1975451
- GTPL9549
- SCHEMBL19457660
- SCHEMBL18989301
- CHEMBL3544911
- EX-A758
- DOTGPNHGTYJDEP-UHFFFAOYSA-N
- AOB87325
- ZINC95837013
- Prexasertib (LY2606368)
- 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile
- LY2606368 mesylate monohydrate
- 2-Pyrazinecarbonitrile, 5-((5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)-
- 2-Pyrazinecarbonitrile, 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-
- PREXASERTIB [INN]
- Prexasertib (USAN/INN)
- LY2606368;Prexasertib
- PREXASERTIB [WHO-DD]
- DTXSID301031326
- BCP14380
- BDBM50524300
- MFCD25977016
- NSC758257
- NSC789570
- DB12008
- NSC-758257
- NSC-789570
- SB16662
- NCGC00390643-02
- NCGC00390643-06
Look up PREXASERTIB in the interactive SynDRA portal →